This test would be indicated in a patient with symptoms of immune deficiency when the routine immunological assessments have not been instructive.
Heparinized whole blood is stimulated with TLR ligands or left unstimualted (as background) and the cultured cells are incubated at 37°C. Following the stimulation phase, the plasma is recovered and analyzed for TNF-alpha by an Meso Scale Discovery (MSD®) Electrochemiluminescent Assay. This test has not been cleared or approved for diagnostic use by the U.S. Food and Drug Administration.
5-7 business days from receipt of specimen
|Specimen Type||Order Code||CPT Code||NY Approved||Volume||Assay Range||Special Instructions|
|whole blood||403091P||86352||Yes||8 mL||Varies by antigen/mitogen||
Specimens are approved for testing in New York only when indicated in the Specimen Information field above.
The CPT codes provided are based on Viracor Eurofins' interpretation of the American Medical Association's Current Procedural Terminology (CPT) codes and are provided for general informational purposes only. CPT coding is the sole responsibility of the billing party. Questions regarding coding should be addressed to your local Medicare carrier. Viracor Eurofins assumes no responsibility for billing errors due to reliance on the CPT codes illustrated in this material.